Tuesday, July 17, 2018      
Choose Language  

Neofor - Plerixafor

Drug Name : Neofor - Plerixafor
Drug Category : AntineoPlastics
Pharmacological Category: عامل اثرگذار روی خون/hematopoietic agent
Brand Name : Neofor
Drug Forms :

Single-use vial containing 1.2 mL of a 20 mg/mL solution.


Based on limited data at doses above the recommended dose of 0.24 mg/kg SC, the frequency of gastrointestinal disorders, vasovagal reactions, orthostatic hypotension, and/or syncope may be higher.

FDA Approval

FDA approved plerixafor as as haematopoietic agent on Dec. 2008